Skip to content

MDMA: all studies

Page 264 of 346: studies 2,631 to 2,640 of 3,454, newest first. Back to the MDMA overview

Research

Sacred Drugs

August 8, 2025 Gary Laderman 2 citations

Sacred Drugs explores the numerous ways in which psychoactive substances, from alcohol to psilocybin, cannabis to pharmaceuticals, and coffee to tobacco, intersect with religious life. This cutting-edge volume acknowledges the ubiquity of drug use in American society and that, in fact, being drugged with an altered state of consciousness is a common feature of American life today, as it has...

Salvador Dalí’s Liquid and Gaseous Television a Mystical and Wireless Dream

VIEW Journal of European Television History and Culture August 7, 2025 Anna Luigia de Simone

How can you reach the sky? For Salvador Dalí, just turn on your TV. That is, the Liquid and Gaseous Television: one of his inventions (1975) turning TV into a vehicle for cosmic voyages that allow man to communicate with the universe. Perhaps even with God. This device needs no wires. In it, communicative and transcendental horizons converge, updating the surrealist techniques of activating the...

Beyond the Journey: A Qualitative Analysis of Therapists’ Perspectives on Psychedelic Integration Challenges

Research Square August 5, 2025 Christina Chwyl, Odin S. Elvenes, Andrew S. R. Kleven et al. 2 citations preprint

Abstract Background Psychedelic integration is widely acknowledged as essential, yet limited empirical data exists on challenges faced during integration. Objective To explore therapists' perspectives on post-psychedelic integration challenges and their approaches to supporting clients. Methods Online interviews were conducted with a purposive sample of licensed mental health professionals who...

DOI: 10.21203/rs.3.rs-6874539/v1 (opens in new tab) Full text (opens in new tab) Qualitative research Qualitative analysis Engineering ethics Social science

Latent Classes of Lifetime Use of Seven Hallucinogens in the United States

Journal of Psychoactive Drugs August 4, 2025 Meredith C Meacham, Maha N. Mian, Ralph C. Wang et al. 2 citations

Interest in and use of hallucinogens appears to be growing in the United States, yet less is known about the use of multiple hallucinogens. The aims of this study are to characterize subgroups of lifetime hallucinogen use and to identify sociodemographic correlates of these subgroups. Latent class models were fit using 2021-2022 National Survey on Drug Use and Health (NSDUH) data on a...

Strong increase in the number of intoxications involving psychoactive drugs among adolescents reported to the Dutch Poisons Information Center from 2014-2023.

International Journal of Drug Policy August 1, 2025 Ilze Mj Thoonen, Saskia J. Rietjens, Arjen Koppen et al. 1 citation

The use of psychoactive drugs has been increasing worldwide, with adolescents and young adults accounting for a large share of people who use drugs. To date, there is limited information on trends of intoxications with psychoactive drugs among adolescents, particularly with regard to New Psychoactive Substances (NPS). A retrospective study was performed from 2014-2023 to characterize...

DOI: 10.1016/j.drugpo.2025.104860 (opens in new tab) Full text (opens in new tab) Substance intoxication Drug trends Adolescent Illicit drugs +5

Tusibí: Ni 2C-B ni “cocaína rosa”

Health and Addictions/Salud y Drogas July 29, 2025 Diego Fernández Piedra, Claudio Vidal Giné, Berta de la Vega Moreno 2 citations

El tusi o tusibí es una sustancia psicoactiva de composición variable que ha sido erróneamente asociada con la 2C-B y denominada “cocaína rosa” en discursos policiales y mediáticos. Su uso se ha expandido desde Colombia hacia América Latina, Europa y España, especialmente en contextos recreativos. Aunque la prevalencia general es baja, estudios realizados entre 2020 y 2024 muestran un notable...

Detección de fentanilo en estimulantes y reducción de daños en ciudades de México. Resultados de una intervención piloto desde Aguascalientes

Cultura y Droga July 28, 2025 Alejandra García de Loera, Liliana García de Loera, Jaime Arredondo-Sánchez Lira

El objetivo de este estudio fue explorar la presencia de fentanilo en estimulantes ilegalizados en el centro occidente de México, con el fin de complementar el panorama epidemiológico local y llenar el vacío de investigación sobre este opioide. Se realizaron pruebas en 151 muestras de cristal, cocaína y MDMA recolectadas en la ciudad de Aguascalientes, y no se detectó fentanilo en ninguna de...

DOI: 10.17151/culdr.2024.29.38.8 (opens in new tab) Full text (opens in new tab) Fentanilo Detección Reducción de daños Testeo de sustancias +1

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction July 24, 2025 Amandine Luquiens, Dahbia Belahda, Carine Graux et al. 22 citations

Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted psychotherapy for patients with comorbid...

DOI: 10.1111/add.70152 (opens in new tab) Alcohol use disorder Dual disorders Feasibility Psychedelics +14

Rise of the Mushrooms: Effects of Psilocybin Reforms on Psychedelic Usage Patterns

Journal of Public Policy & Marketing July 16, 2025 Ashutosh Bhave 1 citation

This study examines the relationship between psilocybin reforms and usage patterns of prevalent psychedelics in the United States. Given decriminalization efforts in several cities and legalization in Oregon, the author analyzes drug use panel data from University of Michigan's Monitoring the Future project to assess changes in self-reported use of psilocybin, lysergic acid diethylamide (LSD),...

Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers

Australian & New Zealand Journal of Psychiatry July 15, 2025 Zohaib Nadeem, Stephen Parker, Hugh McGovern et al. 7 citations

Background: Recent regulatory changes in Australia have approved 3,4-methylenedioxymethamphetamine for treating post-traumatic stress disorder and psilocybin for treatment-resistant depression. However, limited data exists on Australian mental healthcare providers’ attitudes, knowledge and readiness to implement with psychedelic-assisted psychotherapy. Methods: A cross-sectional survey was...

DOI: 10.1177/00048674251346679 (opens in new tab) Psilocybin Mental healthcare Health care Psychotherapist